Pelthos Therapeutics, Inc. (PTHS)
26.75
-0.35
(-1.29%)
USD |
NYAM |
May 22, 16:00
26.75
0.00 (0.00%)
After-Hours: 20:00
Pelthos Therapeutics EPS Diluted (Quarterly) : -3.091 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CytomX Therapeutics, Inc. | -0.1029 |
| Cibus, Inc. | -0.3255 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Agenus, Inc. | 1.023 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.24M |
| Revenue (Quarterly) | 10.91M |
| Total Expenses (Quarterly) | 21.14M |
| Enterprise Value | 38.58M |
| Gross Profit Margin (Quarterly) | 70.91% |
| Profit Margin (Quarterly) | -93.87% |
| Earnings Yield | -77.19% |
| Normalized Earnings Yield | -68.63 |